Non-human primate immune libraries combined with germline humanization: An (almost) new, and powerful approach for the isolation of therapeutic antibodies

mAbs

Volumn 1, Issue 4, 2009, Pages 377-381

  Pelat, Thibaut ^a   Thullier, Philippe ^a  

^a CENTRE DE RECHERCHES   (France)

Author keywords

Affinity; Antibody; Epitope; Immune library; Na ve library; Non human primate; Patent; Synthetic library; Tolerance

Indexed keywords

EPITOPE; RECOMBINANT ANTIBODY;

ANTIBODY AFFINITY; ANTIBODY ISOLATION; ANTIBODY PRODUCTION; ANTIGEN BINDING; CROSS REACTION; DRUG EFFICACY; DRUG TOLERANCE; GERM LINE; HUMAN; NONHUMAN; PATENT; PRIMATE; REVIEW;

EID: 77649270848     PISSN: 19420862     EISSN: None     Source Type: Journal    
DOI: 10.4161/mabs.1.4.8635     Document Type: Review

References (34)

1. Burton DR. A model for neutralization of viruses based on antibody caoting of the virion surface. Antibodies in viral infection. Berlin; New York: Springer 2001; 109-143
2. Schellekens H. Immunogenicity of therapeutic proteins: clinical implications and future prospects. Clin Ther 2002; 24:1720-1740 (Pubitemid 35440946)
3. Harris WJ, Adair JR. Humanized antibodies. In Antibody Therapeutics. Boca Raton, Fla.: CRC Press 1997; 6:85-110.
4. Griffiths AD, Williams SC, Hartley O, Tomlinson IM, Waterhouse P, Crosby WL, et al. Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBO J 1994; 13:3245-3260 (Pubitemid 24226939)
5. Persson MA, Caothien RH, Burton DR. Generation of diverse high-affinity human monoclonal antibodies by repertoire cloning. Proc Natl Acad Sci USA 1991; 88:2432-2436
6. Sheets MD, Amersdorfer P, Finnern R, Sargent P, Lindquist E, Schier R, et al. Efficient construction of a large nonimmune phage antibody library: the production of high-affinity human single-chain antibodies to protein antigens. Proc Natl Acad Sci USA 1998; 95:6157-6162 (Pubitemid 28248981)
7. Hoet RM, Cohen EH, Kent RB, Rookey K, Schoonbroodt S, Hogan S, et al. Generation of high-affinity human antibodies by combining donor-derived and synthetic complementarity-determining-region diversity. Nat Biotechnol 2005; 23:344-348 (Pubitemid 41094423)
8. Tonegawa S. Somatic generation of antibody diversity. Nature 1983; 302:575-581
9. Max E, Paul WE. Immunoglobulins: molecular genetics. Fundamental immunology. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins 2008; 1603-1616
10. Chassagne S, Laffly E, Drouet E, Herodin F, Lefranc MP, Thullier P. A high-affinity macaque antibody Fab with human-like framework regions obtained from a small phage display immune library. Mol Immunol 2004; 41:539-546 (Pubitemid 38750199)
11. Laffly E, Danjou L, Condemine F, Vidal D, Drouet E, Lefranc MP, et al. Selection of a macaque Fab with framework regions like those in humans, high affinity and ability to neutralize the protective antigen (PA) of Bacillus anthracis by binding to the segment of PA between residues 686 and 694. Antimicrob Agents Chemother 2005; 49:3414-3420
12. Pelat T, Hust M, Laffly E, Condemine F, Bottex C, Vidal D, et al. High-affinity, human antibody-like antibody fragment (single-chain variable fragment) neutralizing the lethal factor (LF) of Bacillus anthracis by inhibiting protective antigen-LF complex formation. Antimicrob Agents Chemother 2007; 51:2758-2764
13. Pelat T, Hust M, Hale M, Lefranc MP, Dübel S, Thullier P. Isolation of a human-like antibody fragment (scFv) that neutralizes ricin biological activity. BMC Biotech 2009; In Press.
14. Karlsson R, Michaelsson A, Mattsson L. Kinetic analysis of monoclonal antibody-antigen interactions with a new biosensor based analytical system. J Immunol Methods 1991; 145:229-240
15. Schuck P, Minton AP. Analysis of mass transport-limited binding kinetics in evanescent wave biosensors. Anal Biochem 1996; 240:262-272 (Pubitemid 26304270)
16. Hust M, Dubel S, Schirrmann T. Selection of recombinant antibodies from antibody gene libraries. Methods Mol Biol 2007; 408:243-255
17. Kirsch MI, Hulseweh B, Nacke C, Rulker T, Schirrmann T, Marschall HJ, et al. Development of human antibody fragments using antibody phage display for the detection and diagnosis of Venezuelan equine encephalitis virus (VEEV). BMC Biotechnol 2008; 8:66.
18. Wild MA, Xin H, Maruyama T, Nolan MJ, Calveley PM, Malone JD, et al. Human antibodies from immunized donors are protective against anthrax toxin in vivo. Nat Biotechnol 2003; 21:1305-1306 (Pubitemid 37356614)
19. Mohamed N, Li J, Ferreira CS, Little SF, Friedlander AM, Spitalny GL, et al. Enhancement of anthrax lethal toxin cytotoxicity: a subset of monoclonal antibodies against protective antigen increases lethal toxin-mediated killing of murine macrophages. Infect Immun 2004; 72:3276-3283 (Pubitemid 38697749)
20. Amersdorfer P, Wong C, Smith T, Chen S, Deshpande S, Sheridan R, et al. Genetic and immunological comparison of anti-botulinum type A antibodies from immune and nonimmune human phage libraries. Vaccine 2002; 20:1640-1648 (Pubitemid 34169806)
21. Rosenwasser LJ, Busse WW, Lizambri RG, Olejnik TA, Totoritis MC. Allergic asthma and an anti-CD23 mAb (IDEC-152): results of a phase I, single-dose, dose-escalating clinical trial. J Allergy Clin Immunol 2003; 112:563-570
22. Schopf RE. Idec-114 (Idec). Curr Opin Investig Drugs 2001; 2:635-638
23. Kawamura S, Saitou N, Ueda S. Concerted evolution of the primate immunoglobulin alpha-gene through gene conversion. J Biol Chem 1992; 267:7359-7367
24. Andris JS, Miller AB, Abraham SR, Cunningham S, Roubinet F, Blancher A, et al. Variable region gene segment utilization in rhesus monkey hybridomas producing human red blood cell-specific antibodies: predominance of the VH4 family but not VH4-21 (V4-34). Mol Immunol 1997; 34:237-253 (Pubitemid 27293739)
25. Kawamura S, Omoto K, Ueda S. Evolutionary hypervariability in the hinge region of the immunoglobulin alpha gene. J Mol Biol 1990; 215:201-206 (Pubitemid 20329739)
26. Meek K, Eversole T, Capra JD. Conservation of the most JH proximal Ig VH gene segment (VHVI) throughout primate evolution. J Immunol 1991; 146:2434-2438
27. Andris-Widhopf J, Steinberger P, Fuller R, Rader C, Barbas CF. Protocol 9.36: Librairies of nonhuman primate anibody fragments. In: Barbas CF, ed. Phage display: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press 2001; 1.
28. Lefranc MP, Pommie C, Ruiz M, Giudicelli V, Foulquier E, Truong L, et al. IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains. Dev Comp Immunol 2003; 27:55-77. (Pubitemid 35449624)
29. Brochet X, Lefranc MP, Giudicelli V. IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res 2008; 36:503-508
30. Lefranc MP, Giudicelli V, Ginestoux C, Jabado-Michaloud J, Folch G, Bellahcene F, et al. IMGT, the international ImMunoGeneTics information system. Nucleic Acids Res 2009; 37:1006-1012
31. Pelat T, Bedouelle H, Rees AR, Crennell SJ, Lefranc MP, Thullier P. Germline Humanization of a Non-human Primate Antibody that Neutralizes the Anthrax Toxin, by in Vitro and in Silico Engineering. J Mol Biol 2008; 384:1400-1407
32. Magdelaine-Beuzelin C, Kaas Q, Wehbi V, Ohresser M, Jefferis R, Lefranc MP, et al. Structure-function relationships of the variable domains of monoclonal antibodies approved for cancer treatment. Crit Rev Oncol Hematol 2007; 64:210-225 (Pubitemid 350030959)
33. Newman RAN. Hanna N, Raab RW. Recombinant antibodies for human therapy. U.S. patent 5,693,780. 1997.
34. Newman RAN, Hanna N, Raab RW. Recombinant antibodies for human therapy. European patent 1,266,965 B1. 1992.